Creates industrial molecules that can be produced via fermentation to meet demand in commercial markets SEATTLE (November 3, 2016) Arzeda has reached a major technical milestone with Amyris, Inc. (Nasdaq:AMRS) as a part of a Defense Advanced Research Projects Agency (DARPA) [...]
Capacity to Produce 60 Million Friendly™ Aedes per Week can Help Protect Up to 3 Million Brazilians from Primary Vector for Zika, Dengue and other Viruses OXFORD, England, Oct. 26, 2016 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in [...]
By: Kevin Holden, PhD, Head of Synthetic Biology at Synthego Abstract: In this article, we'll discuss the important role CRISPR may play in the future of food amidst challenges of feeding the world's growing population. We'll also take a look [...]
LA JOLLA, CA – October 5, 2016 – SGI-DNA, a Synthetic Genomics, Inc. company, announced today that it is making Syn2.0™ and Syn3.0™ Minimal Synthetic Cells commercially available to researchers worldwide. With genomes smaller than any known naturally occurring bacterium, Syn2.0™ [...]
SAN FRANCISCO--(BUSINESS WIRE)--Riffyn announced today the launch of its cloud-based research process design software at the SynBioBeta SF 2016 conference. The launch follows a successful beta trial period, in which more than 40 organizations participated. Riffyn’s product delivers a step-change [...]
EMERYVILLE & SAN FRANCISCO, Calif., (October 4, 2016) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, in collaboration with the Autodesk BioNano Research Group, today announced the immediate availability of powerful open source tools for genetic design that leverage Autodesk’s [...]
